Analysis of the Global Sepsis Pipeline, 2024 with Insights on 30+ Companies and 35+ Pipeline Drugs, Including Thymosin Alpha 1 (Sci Clone Pharmaceuticals) and Enibarcimab (AdrenoMed)
31. Mai 2024 06:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
Global Sepsis Therapeutics Strategic Research Report 2024: Market to Reach $7.1 Billion by 2030 - Market Receives Pulsating Impetus from North America, Asia-Pacific to Witness Fastest Growth
19. April 2024 06:28 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Sepsis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Sepsis Therapeutics Market...
Global Sepsis Therapeutics Market Research Report 2023 - Revolutionizing Clinical Sepsis Therapy with Breakthrough Nanoparticles
09. Oktober 2023 06:18 ET
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Sepsis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Sepsis Therapeutics Market...
Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Merck, Shionogi, Sentien Biotechnologies, Basilea, Vivacelle Bio, Sanofi, BioAegis, Pharmazz
29. Juni 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, June 29, 2023 (GLOBE NEWSWIRE) -- Sepsis Market Size and Share to Grow by 2032, Examines DelveInsight | Key Companies Developing Therapies - Regeneron, Merck, Shionogi, Sentien...
Sepsis Drug Pipeline Research Report 2022: Comprehensive Insights about 40+ Companies and 40+ Pipeline Drugs
15. Dezember 2022 08:13 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
Promising Treatment for Sepsis Enters Clinical Trials: A Pipeline Products Review by DelveInsight
08. April 2021 20:00 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , April 08, 2021 (GLOBE NEWSWIRE) -- Promising Treatment for Sepsis Enters Clinical Trials: A Pipeline Products Review by DelveInsight The Sepsis pipeline is robust, with...
2021 Sepsis Pipeline Insight with 40+ Companies and 40+ Pipeline Durgs
05. März 2021 04:13 ET
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Sepsis Pipeline Insight 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about...